DE69800699T2 - Verbindungen - Google Patents
VerbindungenInfo
- Publication number
- DE69800699T2 DE69800699T2 DE69800699T DE69800699T DE69800699T2 DE 69800699 T2 DE69800699 T2 DE 69800699T2 DE 69800699 T DE69800699 T DE 69800699T DE 69800699 T DE69800699 T DE 69800699T DE 69800699 T2 DE69800699 T2 DE 69800699T2
- Authority
- DE
- Germany
- Prior art keywords
- pct
- sec
- date
- pub
- links
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Valve-Gear Or Valve Arrangements (AREA)
- Liquid Crystal (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9702002A SE9702002D0 (sv) | 1997-05-28 | 1997-05-28 | Novel compounds |
PCT/SE1998/000940 WO1998054180A1 (en) | 1997-05-28 | 1998-05-18 | Novel compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69800699D1 DE69800699D1 (de) | 2001-05-17 |
DE69800699T2 true DE69800699T2 (de) | 2001-09-06 |
Family
ID=20407125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69800699T Expired - Fee Related DE69800699T2 (de) | 1997-05-28 | 1998-05-18 | Verbindungen |
Country Status (12)
Country | Link |
---|---|
US (1) | US6162808A (de) |
EP (1) | EP0984963B1 (de) |
JP (1) | JP2002501528A (de) |
AT (1) | ATE200489T1 (de) |
AU (1) | AU7681198A (de) |
DE (1) | DE69800699T2 (de) |
DK (1) | DK0984963T3 (de) |
ES (1) | ES2156444T3 (de) |
GR (1) | GR3036195T3 (de) |
PT (1) | PT984963E (de) |
SE (1) | SE9702002D0 (de) |
WO (1) | WO1998054180A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1356299A (en) * | 1997-11-21 | 1999-06-15 | Astra Pharmaceuticals Limited | New compounds which are p2-purinoceptor 7-transmembrane (tm) g-protein coupled receptor antagonists |
AU5716901A (en) * | 2000-04-21 | 2001-11-07 | New England Medical Ct | G protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
US7696168B2 (en) * | 2000-04-21 | 2010-04-13 | Tufts Medical Center, Inc. | G protein coupled receptor agonists and antagonists and methods of activating and inhibiting G protein coupled receptors using the same |
US20030151980A1 (en) * | 2002-02-13 | 2003-08-14 | Isador Farash | Color referenced multi-time watch |
AUPS160602A0 (en) | 2002-04-08 | 2002-05-16 | University Of Queensland, The | Therapeutic method |
AU2002952086A0 (en) * | 2002-10-16 | 2002-11-07 | The University Of Queensland | Treatment of osteoarthritis |
EP2380904A1 (de) * | 2004-11-04 | 2011-10-26 | Tufts Medical Center, Inc. | G-Protein-gekoppelte Rezeptor-Agonisten und Antagonisten sowie Verwendungsverfahren |
US7589213B2 (en) | 2007-04-27 | 2009-09-15 | Old David W | Therapeutic substituted lactams |
EP2291346A2 (de) | 2008-05-15 | 2011-03-09 | Allergan, Inc. | Therapeutische substituierte cyclopentane |
CN103159641A (zh) * | 2011-12-14 | 2013-06-19 | 天津泰普药品科技发展有限公司 | 托伐普坦中间体2-甲酸-5-(2-甲基苯甲酰氨基)甲苯的制备方法 |
EP2881390A1 (de) | 2013-12-04 | 2015-06-10 | Sanofi | Thienomethylpiperazinderivate als Inhibitoren der löslichen Epoxidhydrolase |
CN106045937B (zh) * | 2016-06-21 | 2019-04-16 | 杭州诺维和医药技术有限公司 | 一种{2-[2-(2-氨基-4-噻唑基)-乙酰基氨基]-4-噻唑基}-乙酸的合成方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2099868C (en) * | 1991-01-31 | 2002-04-02 | Thomas Richard Belliotti | Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines |
IT1277373B1 (it) * | 1995-07-28 | 1997-11-10 | Consiglio Nazionale Ricerche | Impiego di composti agonisti o antagonisti dei recettori purinici p2 per la prevenzione della citotossicita' da glutammato |
-
1997
- 1997-05-28 SE SE9702002A patent/SE9702002D0/xx unknown
-
1998
- 1998-05-18 EP EP98924708A patent/EP0984963B1/de not_active Expired - Lifetime
- 1998-05-18 WO PCT/SE1998/000940 patent/WO1998054180A1/en active IP Right Grant
- 1998-05-18 PT PT98924708T patent/PT984963E/pt unknown
- 1998-05-18 DK DK98924708T patent/DK0984963T3/da active
- 1998-05-18 AU AU76811/98A patent/AU7681198A/en not_active Abandoned
- 1998-05-18 AT AT98924708T patent/ATE200489T1/de not_active IP Right Cessation
- 1998-05-18 US US09/091,187 patent/US6162808A/en not_active Expired - Fee Related
- 1998-05-18 DE DE69800699T patent/DE69800699T2/de not_active Expired - Fee Related
- 1998-05-18 JP JP50056799A patent/JP2002501528A/ja active Pending
- 1998-05-18 ES ES98924708T patent/ES2156444T3/es not_active Expired - Lifetime
-
2001
- 2001-07-10 GR GR20010401043T patent/GR3036195T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
SE9702002D0 (sv) | 1997-05-28 |
DK0984963T3 (da) | 2001-06-05 |
ATE200489T1 (de) | 2001-04-15 |
AU7681198A (en) | 1998-12-30 |
US6162808A (en) | 2000-12-19 |
DE69800699D1 (de) | 2001-05-17 |
EP0984963A1 (de) | 2000-03-15 |
WO1998054180A1 (en) | 1998-12-03 |
EP0984963B1 (de) | 2001-04-11 |
JP2002501528A (ja) | 2002-01-15 |
GR3036195T3 (en) | 2001-10-31 |
PT984963E (pt) | 2001-07-31 |
ES2156444T3 (es) | 2001-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9702651D0 (sv) | Novel compounds | |
EP0903349A3 (de) | CCR-3-Rezeptor-Antagonisten | |
BR0015963A (pt) | Compostos de uréia antagonistas receptor muscarìnico, composições farmacêuticas compreendendo tais compostos e método de preparação destes compostos | |
WO2003086303A3 (en) | Farnesoid x-activated receptor agonists | |
ES2160525A1 (es) | Derivados de la 4-aroilpiperidina antagonistas de los receptores ccr-3 | |
NO983002L (no) | Vitronectin-reseptor-antagonister | |
ATE331726T1 (de) | Adenine-derivate | |
DE69532162D1 (de) | Cannabinoid-rezeptor-antagonisten | |
NO20032253D0 (no) | Piperazinylpyrazinforbindelser som antagonister av serotonin 5-HT2-reseptorer | |
DE69800699T2 (de) | Verbindungen | |
HUP0100705A2 (hu) | Hatóanyag-kombinációk alkalmazása, valamint ilyen kombinációkat tartalmazó gyógyszerkészítmények és készletek impotencia kezelésére | |
MX9801890A (es) | Nuevos compuestos antagonistas selectivos del receptor nk3 humano, procedimiento para su obtencion y composiciones farmaceuticas que los contienen. | |
SE9702794D0 (sv) | New compounds | |
NO996442L (no) | Anvendelse av en spesifikk antagonist for 5HT2 reseptorer for fremstilling av medisiner som er anvendbare for behandling av søvnapnésyndromet | |
NO995685D0 (no) | Nye glycosylerte ginkgolidderivater, anvendelse derav som medikamenter og farmasöytiske blandinger | |
FR2690847B1 (fr) | Compositions a activite agoniste des recepteurs analogues a 5ht1 selective. | |
HUP0004900A2 (hu) | Mozgászavarok kezelésére szolgáló, hatóanyagként NMDA-receptor antagonista hatású piperidinszármazékokat tartalmazó gyógyszerkészítmények | |
ATE384066T1 (de) | Thieno-pyrrole verbindungen als antagonisten der gonadotropin-freisetzenden hormonrezeptoren | |
ES2172939T3 (es) | Nuevos compuestos que son antagonistas de receptores acoplados a proteina g de 7-transmembrana (tm) de p2-purinoceptores. | |
NO20000654L (no) | 1,3-dioksolo/4.5-H/2.3/Benzodiazepinderivater som AMPA/kainareseptorinhibitorer | |
ECSP972049A (es) | Derivados de lactama |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |